CNTGF — Crown LiquidationCo NV in liquidatie Share News
0.000.00%
Last trade - 00:00TechnologySpeculativeMicro Cap
- $3.48m
- $74.53m
- €48.54m
Brief: Centogene Says Finds SARS-CoV-2 Variant B.1.525 When Sequencing Positive Results
Brief: Centogene Reports Third-Quarter 2020 Financial Results And Increases Full Year Guidance
Brief: Centogene NV Says Co And Alnylam Pharmaceuticals Announced Launch Of A New Joint Clinical Screening Program
Brief: Centogene NV - Expands Partnership With PTC Therapeutics To Generate New Insights For Aromatic L-Amino Acid Decarboxylase Deficiency
Brief: Centogene Announces Nomination Of Jonathan Sheldon To Supervisory Board
Brief: Centogene And Fujirebio Europe Enter Partnership For COVID-19 Antigen Testing
Brief: Centogene Opens Walk-In Covid-19 Testing Facility
Brief: Centogene NV Announces Leadership Transition
Brief: Centogene NV Increases Full-Year 2020 Guidance
Centogene: Up as U.S. FDA grants emergency use for COVID-19 test
Brief: Centogene Receives FDA Emergency Use Authorization For Sars-Cov-2 Rt-Pcr Assay For Individuals Without Symptoms Or Other Reasons To Suspect Covid-19
Brief: Centogene And U-Diagnostics Announce Collaboration
Brief: Collaboration Between Centogene And U-Diagnostics Increases COVID-19 Testing Capacities In Netherlands
Centogene BV: Tumbles on weak quarterly revenue
Brief: Centogene Expands Covid-19 Testing Capacity At Frankfurt Airport
Brief: Centogene Publishes Dataset That Supports Genome Sequencing As First-Line Diagnostic Test
Brief: Evotec And Centogene Expand Collaboration Into Gaucher Disease
Brief: Centogene Supports Tajikistan in Fight Against the COVID-19 Pandemic
Brief: Centogene, Molecular Health Collaborate To Transform Development Of Orphan Drugs